Vandetanib-induced phototoxicity in human keratinocytes NCTC-2544

Alessia Salvador1, Daniela Vedaldi1, Paola Brun2

  • 1Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Marzolo 5, 35131 Padova, Italy.

Insights

The anticancer drug vandetanib causes significant phototoxicity in skin cells, leading to cell death. This photosensitivity is linked to DNA damage and oxidative stress, not its photoproducts.

Area of Science:

  • Photobiology
  • Dermatology
  • Oncology

Background:

  • Vandetanib is an anticancer drug with reported photosensitizing reactions.
  • Clinical cases highlight the need to understand vandetanib's phototoxicity.

Purpose of the Study:

  • To evaluate the phototoxicity of vandetanib in human keratinocytes.
  • To investigate the mechanisms underlying vandetanib-induced photosensitivity.

Main Methods:

  • Exposure of NCTC-2544 human keratinocytes to vandetanib and UV-A irradiation.
  • Analysis of cell viability, photoproduct formation, DNA photodamage, lipid peroxidation, and protein oxidation.
  • Assessment of apoptosis and cellular organelle involvement (mitochondria, lysosomes).

Main Results:

  • Vandetanib significantly reduced keratinocyte viability in a dose- and UV-A dependent manner.
  • Identified photoproducts did not significantly contribute to phototoxicity.
  • Evidence suggests aryl radical formation, leading to extensive DNA photodamage, lipid peroxidation, and protein oxidation.
  • Vandetanib photoinduced apoptosis via mitochondrial and lysosomal pathways.

Conclusions:

  • Vandetanib exhibits significant phototoxicity mediated by reactive species formation and subsequent cellular damage.
  • The primary mechanism involves DNA damage and oxidative stress, rather than photoproducts.
  • Understanding these mechanisms is crucial for managing vandetanib-related photosensitivity in patients.